Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
9
RCEL Quote, Financials, Valuation and Earnings
Last price:
$3.55
Seasonality move
:
-1.03%
Day range:
$3.50 - $3.63
52-week range:
$3.35 - $14.16
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.30x
P/B ratio:
40.83x
Volume:
240.4K
Avg. volume:
197.9K
1-year change:
-72.37%
Market cap:
$107M
Revenue:
$64.3M
EPS (TTM):
-$1.81
Analysts' Opinion
-
Consensus RatingAVITA Medical, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 2 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $7.92, AVITA Medical, Inc. has an estimated upside of 124.65% from its current price of $3.55.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $3.02 representing 100% downside risk from its current price of $3.55.
Fair Value
-
According to the consensus of 6 analysts, AVITA Medical, Inc. has 124.65% upside to fair value with a price target of $7.92 per share.
RCEL vs. S&P 500
-
Over the past 5 trading days, AVITA Medical, Inc. has underperformed the S&P 500 by -6.41% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
AVITA Medical, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
AVITA Medical, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter AVITA Medical, Inc. reported revenues of $17.1M.
Earnings Growth
-
AVITA Medical, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter AVITA Medical, Inc. reported earnings per share of -$0.46.
Enterprise value:
128.5M
EV / Invested capital:
3.37x
Price / LTM sales:
1.30x
EV / EBIT:
--
EV / Revenue:
1.77x
PEG ratio (5yr expected):
-1.47x
EV / Free cash flow:
-3.51x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$60.6M
Return On Assets:
-68.94%
Net Income Margin (TTM):
-67.07%
Return On Equity:
-1112.54%
Return On Invested Capital:
-111.55%
Operating Margin:
-53.65%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $45.4M | $60M | $72.4M | $19.5M | $17.1M | |
| Gross Profit | $38.1M | $51.4M | $60.6M | $16.4M | $13.9M | |
| Operating Income | -$38.6M | -$138M | -$42.1M | -$13.8M | -$9.2M | |
| EBITDA | -$37.1M | -$136.8M | -$40.1M | -$13.5M | -$8.6M | |
| Diluted EPS | -$1.33 | -$2.23 | -$1.81 | -$0.62 | -$0.46 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $97.1M | $91.7M | $73.9M | $63.9M | $41.4M | |
| Total Assets | $121.2M | $99.9M | $81M | $81.1M | $63.7M | |
| Current Liabilities | $7.1M | $9.5M | $11.8M | $17.1M | $61.8M | |
| Total Liabilities | $9.7M | $10.7M | $14M | $65.9M | $66.3M | |
| Total Equity | $111.5M | $88M | $63M | $12.2M | -$6.7M | |
| Total Debt | -- | $405K | $1.8M | $45.6M | $44.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$29.5M | -$52M | -$33.4M | -$7.6M | -$5.5M | |
| Cash From Investing | $54.9M | -$20.8M | $14.4M | $7.7M | -$5.3M | |
| Cash From Financing | $1.8M | $41.2M | $15.9M | $1M | $14.1M | |
| Free Cash Flow | -$30.7M | -$60.1M | -$36.6M | -$11.5M | -$6.5M | |
RCEL
Sector
Market Cap
$107M
$28.4M
Price % of 52-Week High
24.79%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-9.47%
-1.32%
1-Year Price Total Return
-73.65%
-22.19%
Beta (5-Year)
1.658
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.67
200-day SMA
Sell
Level
$6.15
Bollinger Bands (100)
Sell
Level
3.9 - 5.54
Chaikin Money Flow
Sell
Level
-3.1M
20-day SMA
Sell
Level
$3.76
Relative Strength Index (RSI14)
Sell
Level
38.50
ADX Line
Sell
Level
17.16
Williams %R
Buy
Level
-86.5672
50-day SMA
Sell
Level
$4.29
MACD (12, 26)
Sell
Level
-0.16
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-4.4871)
Sell
CA Score
(Annual)
Level (-3.8747)
Sell
Beneish M-Score
(Annual)
Level (-1.5795)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (6.3405)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Stock Forecast FAQ
In the current month, RCEL has received 3 Buy ratings 2 Hold ratings, and 1 Sell ratings. The RCEL average analyst price target in the past 3 months is $7.92.
-
Where Will AVITA Medical, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that AVITA Medical, Inc. share price will rise to $7.92 per share over the next 12 months.
-
What Do Analysts Say About AVITA Medical, Inc.?
Analysts are divided on their view about AVITA Medical, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that AVITA Medical, Inc. is a Sell and believe this share price will drop from its current level to $3.02.
-
What Is AVITA Medical, Inc.'s Price Target?
The price target for AVITA Medical, Inc. over the next 1-year time period is forecast to be $7.92 according to 6 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is RCEL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for AVITA Medical, Inc. is a Buy. 3 of 6 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of RCEL?
You can purchase shares of AVITA Medical, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase AVITA Medical, Inc. shares.
-
What Is The AVITA Medical, Inc. Share Price Today?
AVITA Medical, Inc. was last trading at $3.55 per share. This represents the most recent stock quote for AVITA Medical, Inc.. Yesterday, AVITA Medical, Inc. closed at $3.55 per share.
-
How To Buy AVITA Medical, Inc. Stock Online?
In order to purchase AVITA Medical, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get RCEL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RCEL
Sector
P/E ratio
--
23.66x
PEG ratio
-1.47x
-0.01x
P/B ratio
40.83x
1.84x
Price / LTM sales
1.30x
1.60x
Growth Metrics
RCEL
Sector
Revenue growth
-12.71%
4.85%
Earnings growth
25.53%
11.15%
Revenue (5-year growth)
63.43%
6.45%
Earnings forecast
-$0.29
-$0.20
Profitability
RCEL
Sector
Profitability FY 2024
$55.2M
$3.6M
Return on invested capital
-111.55%
-30.98%
Return on assets
-68.94%
-27.62%
Return on equity
-1112.54%
-36.69%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
12
Estimated Next Earnings Date
Feb
5
Balance Sheet
RCEL
Sector
Total cash
$23.3M
$27.2M
Short term investments
$21.8M
$25.7M
Total assets
$79.7M
$79.9M
Long term debt
$44.8M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
39
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
38
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
